Cardiol Therapeutics Inc. (TSX:CRDL)

Cardiol Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 14, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	133	151	72	44	142	91
Market Cap Growth	-13.47%	110.34%	63.29%	-69.05%	55.49%	-22.93%
Enterprise Value	122	135	31	-21	113	75
Last Close Price	1.35	1.85	1.10	0.69	2.33	2.78
PS Ratio	-	-	-	-	1803.25	-
PB Ratio	13.96	6.11	2.54	0.84	1.86	6.88
P/TBV Ratio	13.96	6.11	2.56	0.85	1.87	7.13
EV/Sales Ratio	-	-	-	-	1441.08	-
Debt / Equity Ratio	0.01	0.01	0.01	0.00	0.00	0.01
Asset Turnover	-	-	-	-	0.00	-
Quick Ratio	3.59	4.41	4.25	6.12	7.29	5.66
Current Ratio	3.89	4.52	4.36	6.27	7.54	5.94
Return on Equity (ROE)	-347.98%	-138.47%	-69.93%	-48.16%	-70.69%	-147.74%
Return on Assets (ROA)	-148.83%	-73.43%	-37.71%	-34.47%	-46.58%	-82.38%
Return on Capital (ROIC)	-223.45%	-94.44%	-46.14%	-40.17%	-53.83%	-91.42%
Return on Capital Employed (ROCE)	-375.60%	-162.10%	-104.90%	-79.20%	-50.70%	-154.70%
Earnings Yield	-26.06%	-24.30%	-39.19%	-70.37%	-22.28%	-22.60%
FCF Yield	-18.17%	-16.61%	-35.17%	-62.10%	-16.58%	-10.04%
Buyback Yield / Dilution	-21.91%	-11.02%	-3.13%	-44.61%	-44.77%	-15.63%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.